# Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention

> **NCT06281041** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 4657 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis

## Interventions

- **DRUG:** Antiplatelet Agents

## Key facts

- **NCT ID:** NCT06281041
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 4657 (ACTUAL)
- **Last updated:** 2025-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281041, "Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06281041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*